Furthermore, a case–control association study of 290 individuals demonstrated that PXR polymorphisms were associated with disease severity in NAFLD, as well as increased alanine aminotransferase (ALT) levels, which is a surrogate marker of severe liver injury [76]. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.